N. Lynn Henry, MD, PhD; Anna Beck, MD; Adam Cohen, MD; Saundra Buys, MD; John Ward, MD; Hung Khong, MD; Elizabeth Prystas, MD
The purpose of this study was to better understand why some breast cancer survivors who have chronic pain and are treated with duloxetine will have their level of pain improve, while others do not. The researchers wanted to enroll 56 women with breast cancer who had chronic pain. Participants were treated with duloxetine for 7 weeks in order to determine how the medication affected both their level of pain and their sensitivity to pain.
The initial Call to Action for this study was sent to AOW members on October 4, 2017 and the researchers closed enrollment on June 30, 2019. The AOW provided them with 2 women who were interested in enrolling in the study.